Unknown

Dataset Information

Do we need to adjust for interim analyses in a Bayesian adaptive trial design?


ABSTRACT:

Background

Bayesian adaptive methods are increasingly being used to design clinical trials and offer several advantages over traditional approaches. Decisions at analysis points are usually based on the posterior distribution of the treatment effect. However, there is some confusion as to whether control of type I error is required for Bayesian designs as this is a frequentist concept.

Methods

We discuss the arguments for and against adjusting for multiplicities in Bayesian trials with interim analyses. With two case studies we illustrate the effect of including interim analyses on type I/II error rates in Bayesian clinical trials where no adjustments for multiplicities are made. We propose several approaches to control type I error, and also alternative methods for decision

SUBMITTER: Ryan EG 

PROVIDER: S-EPMC7288484 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature